Lexpos News

Pharmacy press As today marks World Pharmacists Day, an annual awareness day led by the International Pharmaceutical Federation (FIP) – we, at Community Pharmacy England, celebrating the crucial role pharmacists play in improving access to healthcare, ensuring the responsible use of medicines and so much more. This year’s theme, ‘Pharmacy strengthening health systems’, highlights the [...]

The post Celebrating World Pharmacists Day 2023 appeared first on Community Pharmacy England.

Earlier this week, Community Pharmacy England, NHS England and the Department of Health and Social Care won the ‘Patient Safety Team of the Year’ Award at the Health Service Journal (HSJ) Patient Safety Awards. This award was for the Pharmacy Quality Scheme (PQS) patient safety work that community pharmacy teams have participated in. The entry [...]

The post PQS: HSJ Award recognises patient safety work of the community pharmacy sector appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for the Somatropin (Genotropin® MiniQuick) 0.6mg and 1.4mg powder and solvent for solution for injection pre-filled disposable devices. Somatropin (Genotropin® GoQuick) 5.3mg powder and solvent for solution for injection pre-filled, multi-dose pens MSN/2023/089 Tier 2 – medium impact Date of issue 21st [...]

The post Medicine Supply Notification: Somatropin (Genotropin® MiniQuick) 0.6mg, 1.4mg and (Genotropin® GoQuick) 5.3mg powder and solvent for solution for injection pre-filled disposable devices – Update appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for the Discontinuation of lixisenatide (Lyxumia®) 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices MSN/2023/088 Tier 2 – medium impact Date of issue 21st September 2023 Lixisenatide (Lyxumia®) 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices are being discontinued and stock will [...]

The post Medicine Supply Notification: Discontinuation of lixisenatide (Lyxumia® ) 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Hyoscine hydrobromide (Scopoderm®) 1.5mg patches. MSN/2023/087 Tier 2 – medium impact Date of issue 21st September 2023 Hyoscine hydrobromide (Scopoderm®) 1.5mg patches are in limited supply until w/c 1st January 2024. Alternative formulations of hyoscine hydrobromide remain available and will be [...]

The post Medicine Supply Notification: Hyoscine hydrobromide (Scopoderm® ) 1.5mg patches appeared first on Community Pharmacy England.